• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

紫杉醇在大分子纳米壳中的包封。

Encapsulation of paclitaxel in macromolecular nanoshells.

作者信息

Zahr Alisar S, Pishko Michael V

机构信息

Departments of Chemical Engineering, The Pennsylvania State University, University Park, Pennsylvania 16802, USA.

出版信息

Biomacromolecules. 2007 Jun;8(6):2004-10. doi: 10.1021/bm070177m. Epub 2007 May 19.

DOI:10.1021/bm070177m
PMID:17511501
Abstract

An electrostatic layer-by-layer self-assembly technique was used to encapsulate solid core paclitaxel nanoparticles within a polymeric nanometer-scale shell. This approach provides a new strategy for the development of polymeric vehicles that control drug release and target diseased tissues and cells specific to the ailment, such as breast cancer. Core paclitaxel nanoparticles, 153 +/- 28 nm in diameter, were prepared using a modified nanoprecipitation technique. A nanoshell composed of multilayered polyelectrolytes, poly(allylamine hydrochloride) and poly(styrene-4-sulfonate) was assembled stepwise onto core charged drug nanoparticles. In vitro studies were performed to determine the anticancer activity of paclitaxel core-shell nanoparticles. Paclitaxel core-shell nanoparticles induced cell cycle arrest in the G2/M phase after 24 and 48 h of incubation with a human breast carcinoma cell line, MCF-7. Changes in MCF-7 cell morphology, fragmentation of the nucleus, and loss of cell-cell contacts indicated that the cells responded to paclitaxel core nanoparticles upon treatment for 24 and 48 h. Cells arrested in G2/M phase illustrated abnormal microtubule and actin cytoskeleton morphology. The core-shell drug nanoparticles fabricated using this procedure provide a new approach in the delivery of paclitaxel devoid of Cremophor EL, a solvent that causes adverse side effects in patients undergoing chemotherapy for treatment of metastasized mammary cancers.

摘要

采用静电层层自组装技术将固体核心紫杉醇纳米颗粒包裹在聚合物纳米级外壳中。这种方法为开发聚合物载体提供了一种新策略,该载体可控制药物释放并靶向特定疾病(如乳腺癌)的患病组织和细胞。使用改良的纳米沉淀技术制备了直径为153±28 nm的核心紫杉醇纳米颗粒。由多层聚电解质聚(烯丙胺盐酸盐)和聚(苯乙烯-4-磺酸盐)组成的纳米壳逐步组装到带电荷的核心药物纳米颗粒上。进行了体外研究以确定紫杉醇核壳纳米颗粒的抗癌活性。在用人类乳腺癌细胞系MCF-7孵育24小时和48小时后,紫杉醇核壳纳米颗粒诱导细胞周期停滞在G2/M期。MCF-7细胞形态的变化、细胞核的碎片化以及细胞间接触的丧失表明,在处理24小时和48小时后,细胞对紫杉醇核心纳米颗粒有反应。停滞在G2/M期的细胞显示出异常的微管和肌动蛋白细胞骨架形态。使用该程序制备的核壳药物纳米颗粒为紫杉醇的递送提供了一种新方法,该方法不含聚氧乙烯蓖麻油EL,聚氧乙烯蓖麻油EL是一种在转移性乳腺癌化疗患者中会引起不良副作用的溶剂。

相似文献

1
Encapsulation of paclitaxel in macromolecular nanoshells.紫杉醇在大分子纳米壳中的包封。
Biomacromolecules. 2007 Jun;8(6):2004-10. doi: 10.1021/bm070177m. Epub 2007 May 19.
2
Macrophage uptake of core-shell nanoparticles surface modified with poly(ethylene glycol).巨噬细胞对用聚乙二醇表面修饰的核壳纳米颗粒的摄取。
Langmuir. 2006 Sep 12;22(19):8178-85. doi: 10.1021/la060951b.
3
Radiosensitization of paclitaxel, etanidazole and paclitaxel+etanidazole nanoparticles on hypoxic human tumor cells in vitro.紫杉醇、依他硝唑及紫杉醇+依他硝唑纳米粒对体外缺氧人肿瘤细胞的放射增敏作用
Biomaterials. 2007 Sep;28(25):3724-30. doi: 10.1016/j.biomaterials.2007.04.032. Epub 2007 May 3.
4
Encapsulation of drug nanoparticles in self-assembled macromolecular nanoshells.药物纳米颗粒在自组装大分子纳米壳中的包封。
Langmuir. 2005 Jan 4;21(1):403-10. doi: 10.1021/la0478595.
5
The effect of paclitaxel-loaded nanoparticles with radiation on hypoxic MCF-7 cells.载有紫杉醇的纳米颗粒联合辐射对缺氧MCF - 7细胞的影响。
J Clin Pharm Ther. 2007 Feb;32(1):41-7. doi: 10.1111/j.1365-2710.2007.00796.x.
6
Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation.载紫杉醇的聚乙二醇化聚乳酸-羟基乙酸共聚物纳米粒:体内外评价
J Control Release. 2009 Jan 5;133(1):11-7. doi: 10.1016/j.jconrel.2008.09.086. Epub 2008 Oct 9.
7
Characterization and preparation of core-shell type nanoparticle for encapsulation of anticancer drug.用于封装抗癌药物的核壳型纳米粒子的特性描述与制备。
Colloids Surf B Biointerfaces. 2010 Dec 1;81(2):530-6. doi: 10.1016/j.colsurfb.2010.07.053. Epub 2010 Aug 3.
8
Heparin-paclitaxel conjugates as drug delivery system: synthesis, self-assembly property, drug release, and antitumor activity.肝素-紫杉醇偶联物作为药物传递系统:合成、自组装特性、药物释放和抗肿瘤活性。
Bioconjug Chem. 2009 Dec;20(12):2214-21. doi: 10.1021/bc8003809.
9
Characterization and in vitro assessment of paclitaxel loaded lipid nanoparticles formulated using modified solvent injection technique.使用改良溶剂注入技术制备的紫杉醇脂质纳米粒的表征及体外评价
Pharmazie. 2009 May;64(5):301-10.
10
Expansile nanoparticles: synthesis, characterization, and in vivo efficacy of an acid-responsive polymeric drug delivery system.可膨胀纳米颗粒:一种酸响应性聚合物药物递送系统的合成、表征及体内疗效
J Am Chem Soc. 2009 Feb 25;131(7):2469-71. doi: 10.1021/ja807416t.

引用本文的文献

1
Recent advances in drug delivery systems for enhancing drug penetration into tumors.用于增强药物渗透进入肿瘤的给药系统的最新进展。
Drug Deliv. 2020 Dec;27(1):1474-1490. doi: 10.1080/10717544.2020.1831106.
2
Architectural layer-by-layer assembly of drug nanocapsules with PEGylated polyelectrolytes.药物纳米胶囊与聚乙二醇化聚电解质的逐层构筑组装
Soft Matter. 2012 Jan 1;8(36):9418-9427. doi: 10.1039/C2SM25683E. Epub 2012 Jun 25.
3
Paclitaxel in tyrosine-derived nanospheres as a potential anti-cancer agent: in vivo evaluation of toxicity and efficacy in comparison with paclitaxel in Cremophor.
酪氨酸衍生纳米球中的紫杉醇作为一种潜在的抗癌药物:与 Cremophor 中的紫杉醇相比的体内毒性和疗效评价。
Eur J Pharm Sci. 2012 Feb 14;45(3):320-9. doi: 10.1016/j.ejps.2011.11.017. Epub 2011 Dec 3.
4
Therapeutic efficacy of 2-methoxyestradiol microcrystals encapsulated within polyelectrolyte multilayers.聚电解质多层膜包裹的2-甲氧基雌二醇微晶的治疗效果
Macromol Biosci. 2009 May 13;9(5):429-36. doi: 10.1002/mabi.200800381.